More: Health Policy

Report: CMS’ Proposed Rule to Encourage Value-Based Payment Arrangements with Drug Manufacturers

Doctor using laptop for telehealth visit to discuss medication with patient.

The Centers for Medicare and Medicaid Services (CMS) is updating its rules to encourage states, payers, and Medicare programs to enter value-based payment arrangements (VPA) with drug manufacturers to help reduce drug costs. What does this mean for Medicare providers and beneficiaries?

COVID-19 Recommendations from Chief Clinical Officer Keith Fernandez, MD

Privia Health’s Chief Clinical Officer Keith Fernandez, MD, shares his insights on ways providers can combat COVID-19 by leveraging technology, implementing telehealth, and practicing self-care.